August 2019 Price Concessions – 2nd update


August 2019 Price Concessions – 2nd update

August 21, 2019

Department of Health and Social Care (DHSC) has today granted the following list of price concessions:

Drug Pack size Price Concession
Alverine 60mg capsules 100 £9.38
Betahistine 8mg tablets 84 £1.60
Celecoxib 200mg capsules 30 £8.00
Desmopressin 200microgram tablets 30 £14.58
Escitalopram 10mg tablets 28 £3.19
Hydroxychloroquine 200mg tablets 60 £5.74
Ibandronic acid 150mg tablets 1 £9.20
Indapamide 2.5mg tablets 28 £2.89
Irbesartan 150mg tablets 28 £5.79
Irbesartan 300mg tablets 28 £7.97
Levetiracetam 500mg tablets 60 £7.90
Pantoprazole 20mg gastro-resistant tablets 28 £2.20
Pantoprazole 40mg gastro-resistant tablets 28 £2.80
Prednisolone 5mg tablets 28 £3.36
Quinine sulfate 300mg tablets 28 £6.51
Riluzole 50mg tablets 56 £37.00
Risedronate sodium 35mg tablets 4 £13.50
Topiramate 100mg tablets 60 £22.89
Topiramate 50mg tablets 60 £12.30
Valsartan 160mg capsules 28 £12.08

DHSC previously (16.08.2019) granted the following price concessions:

Drug Pack size Price Concession
Betahistine 16mg tablets 84 £2.99
Cyclizine 50mg/1ml solution for injection ampoules 5 £15.93
Escitalopram 20mg tablets 28 £5.00
Escitalopram 5mg tablets 28 £3.25
Metoprolol 100mg tablets 28 £3.40
Metoprolol 50mg tablets 28 £4.85
Mometasone 50micrograms/dose nasal spray 140 £4.49
Montelukast 10mg tablets 28 £4.38
Pizotifen 1.5mg tablets 28 £4.99
Prednisolone sodium phosphate 0.5% ear/eye drops 10ml £2.50
Tamoxifen 20mg tablets 30 £3.75
Tolbutamide 500mg tablets 28 £16.53

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated August 2019 Drug Tariff price. Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.

Posted in: ,

More Latest News >